Patents by Inventor Catherine Leblanc

Catherine Leblanc has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organic Compounds For the Treatment of Inflammatory or Allergic Conditions
    Publication number: 20080200466
    Abstract: Compounds of formula (I) in free or pharmaceutically acceptable salt form, where R1, R2, R3, R4, R5, R6, R7, m, n, w, X, and Y have the meanings as indicated in the specification, are useful for treating conditions mediated by the CRTh2 receptor, especially inflammatory or obstructive airways diseases.
    Type: Application
    Filed: May 22, 2006
    Publication date: August 21, 2008
    Inventors: Jake Axford, Urs Baettig, Brian Cox, Kamlesh Jagdis Bala, Catherine Leblanc, David Andrew Sandham
  • Pyrrolopyridine Derivatives And Their Use As Crth2 Antagonists
    Publication number: 20080114022
    Abstract: There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
    Type: Application
    Filed: June 16, 2005
    Publication date: May 15, 2008
    Inventors: Kamlesh Jagdis Bala, Catherine Leblanc, David Andrew Sandham, Katharine Louise Turner, Simon James Watson, Lyndon Nigel Brown, Brian Cox
  • Pyrazole Derivatives for Treating Condit Ions Mediated by Activation of the Adeno Sine A2B or A3 Receptor
    Publication number: 20070225335
    Abstract: Compounds of formula I in free or salt form, wherein R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating a condition mediated by activation of the adenosine A2b receptor or the adenosine A3 receptor, particularly an inflammatory or obstructive airways disease. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Application
    Filed: August 10, 2005
    Publication date: September 27, 2007
    Inventors: Graham Bloomfield, Catherine Leblanc, Clive McCarthy, Neil Press
  • 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors
    Publication number: 20060148822
    Abstract: Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Application
    Filed: March 5, 2004
    Publication date: July 6, 2006
    Inventors: Graham Bloomfield, Ian Bruce, Catherine Leblanc, Mrinalini Oza, Lewis Whithead, Bernard Cuenoud, Thomas Keller, Louise Kirman, Clive McCarthy, Gaynor Woodward
  • 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
    Publication number: 20050119320
    Abstract: Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Application
    Filed: February 27, 2003
    Publication date: June 2, 2005
    Inventors: Ian Bruce, Peter Finan, Catherine Leblanc, Clive McCarthy, Lewis Whitehead, Nicola Press, Graham Bloomfield, Judy Hayler, Louise Kirman, Mrinalini Oza, Lena Shukla